Evaluation Of The Anxiety Status Of Patients With Hpv-Positive

Abstract

Cervical cancer, which constitutes 4.5% of cancers seen in women, ranks fourth in the world and ninth in Turkey. With the recommendation of the World Health Organization, population-based screening programs are carried out for breast, cervix and colorectal cancers, which are among the first in our country. The share of cancers screened is 35% of all female cancers. In 2016; 2,898,424 people were included in cervical cancer screening programs, resulting in an increase compared to 2015. When the causes of death statistics are examined cancer-related deaths account for approximately 20% of all deaths.
Although early lesions are detected with the HPV test, considering the psychological effects such as depression, anxiety and loss of self-esteem caused by the disease itself, as well as the treatment process that brings pain, sexual problems, loss of workforce, and financial burden, it is important to consider how important the precautions to be taken before the disease occurs. It is open. In this study, the anxiety status of patients whose HPV test results were positive in our clinic between November 2021 and June 2022 was evaluated. The mean anxiety score of the participants is 22.25±8.91. The median is 24. Six of the participants (30%) have low anxiety, 7 (35%) have moderate anxiety, and 7 (35%) have high anxiety.